Nothing Special   »   [go: up one dir, main page]

US20130231694A1 - Intravascular blood filter - Google Patents

Intravascular blood filter Download PDF

Info

Publication number
US20130231694A1
US20130231694A1 US13/738,847 US201313738847A US2013231694A1 US 20130231694 A1 US20130231694 A1 US 20130231694A1 US 201313738847 A US201313738847 A US 201313738847A US 2013231694 A1 US2013231694 A1 US 2013231694A1
Authority
US
United States
Prior art keywords
filter
vessel
tubular member
delivery catheter
artery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/738,847
Inventor
Randall T. Lashinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Claret Medical Inc
Original Assignee
Claret Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Claret Medical Inc filed Critical Claret Medical Inc
Priority to US13/738,847 priority Critical patent/US20130231694A1/en
Publication of US20130231694A1 publication Critical patent/US20130231694A1/en
Assigned to CLARET MEDICAL, INC. reassignment CLARET MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LASHINSKI, RANDALL T.
Priority to US15/838,949 priority patent/US10743977B2/en
Priority to US16/934,962 priority patent/US11364106B2/en
Priority to US17/752,209 priority patent/US12048618B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/013Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/012Multiple filtering units
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2002/018Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0006Rounded shapes, e.g. with rounded corners circular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0008Rounded shapes, e.g. with rounded corners elliptical or oval
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0067Three-dimensional shapes conical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0069Three-dimensional shapes cylindrical

Definitions

  • This invention relates generally to medical devices used during vascular intervention, and more particularly, concerns medical devices that are useful in treating aortic valve replacement, thromboembolic disorders and for removal of foreign bodies in the vascular system.
  • Thromboembolic disorders such as stroke, pulmonary embolism, peripheral thrombosis, atherosclerosis, and the like, affect many people. These disorders are a major cause of morbidity and mortality in the United States and throughout the world. Thromboembolic events are characterized by an occlusion of a blood vessel.
  • the occlusion can be caused by a clot which is viscoelastic (jelly-like) and is comprised of platelets, fibrinogen, and other clotting proteins.
  • Percutaneous aortic valve replacement has been in development for some time now and stroke rates related to this procedure are between four and twenty percent.
  • plaque may be dislodged from the vasculature.
  • the invention contained within will block the emboli from traveling through the carotid circulation and onto the brain.
  • tissue ischemia (lack of oxygen and nutrients) develops.
  • the ischemia will progress to tissue infarction (cell death) if the occlusion persists. Infarction does not develop or is greatly limited if the flow of blood is reestablished rapidly. Failure to reestablish blood-flow can lead to the loss of limb, angina pectoris, myocardial infarction, stroke, or even death.
  • Occlusion of the venous circulation by thrombi leads to blood stasis which can cause numerous problems.
  • the majority of pulmonary embolisms are caused by emboli that originate in the peripheral venous system. Reestablishing blood flow and removal of the thrombus is highly desirable.
  • an embolectomy involves incising a blood vessel and introducing a balloon-tipped device (such as a Fogarty catheter) to the location of the occlusion.
  • a balloon-tipped device such as a Fogarty catheter
  • the balloon is then inflated at a point beyond the clot and used to translate the obstructing material back to the point of incision.
  • the obstructing material is then removed by the surgeon. While such surgical techniques have been useful, exposing a patient to surgery may be traumatic and is best avoided when possible. Additionally, the use of a Fogarty catheter may be problematic due to the possible risk of damaging the interior lining of the vessel as the catheter is being withdrawn.
  • a common percutaneous technique is referred to as balloon angioplasty where a balloon-tipped catheter is introduced into a blood vessel, typically through an introducing catheter. The balloon-tipped catheter is then advanced to the point of the occlusion and inflated in order to dilate the stenosis. Balloon angioplasty is appropriate for treating vessel stenosis but is generally not effective for treating acute thromboembolisms.
  • Another percutaneous technique is to place a microcatheter near the clot and infuse Streptokinase, Urokinase, or other thrombolytic agents to dissolve the clot.
  • Streptokinase Urokinase
  • thrombolytic agents can cause hemorrhage and in many patients the agents cannot be used at all.
  • Another problematic area is the removal of foreign bodies.
  • Foreign bodies introduced into the circulation can be fragments of catheters, pace-maker electrodes, guide wires, and erroneously placed embolic material such as thrombogenic coils.
  • embolic material such as thrombogenic coils.
  • retrieval devices for the removal of foreign bodies certain of such devices form a loop that can ensnare the foreign material by decreasing the size of the diameter of the loop around the foreign body. The use of such removal devices can be difficult and sometimes unsuccessful.
  • systems heretofore disclosed in the art are generally limited by size compatibility and the increase in vessel size as the emboli is drawn out from the distal vascular occlusion location to a more proximal location near the heart. If the embolectomy device is too large for the vessel it will not deploy correctly to capture the clot or foreign body, and if too small in diameter it cannot capture clots or foreign bodies across the entire cross section of the blood vessel. Additionally, if the embolectomy device is too small in retaining volume then as the device is retracted the excess material being removed can spill out and be carried by flow back to occlude another distal vessel.
  • filter devices are delivered from the groin and are placed distal to the flow of the lesion or site in question.
  • Single basket-type filters or Nitinol loop filters are the most common used today in carotid stent procedures of vein graft stenting.
  • the filter is delivered over the guidewire protecting the distal vasculature.
  • the invention here may be delivered from the groin in a conventional manner to vessels such as the carotid arteries or via radial (arm vasculature) approach. Protecting the carotid arteries and cerebral vasculature system is the main goal while leaving the aortic arch free from catheters and wire as much as possible during the delivery of other devices such as aortic balloons and prosthetic valves or other associated devices.
  • One method of filtering the carotid arteries leaving the aorta free from obstruction is to deliver a filter to each of the carotid arteries from the groin leaving them in the carotid vasculature and retrieving them via snare post procedure.
  • a delivery catheter would be inserted through an introducer in the groin (femoral artery) and delivered to the common carotid arteries and detached. The delivery catheter would be removed and a second filter would be delivered in a similar manner to the other carotid artery.
  • two detached filters now in place the procedure treating the aortic or mitral valve can now be completed with embolic protection for the cerebral vascular system. Once the procedure to the valve is completed, the filters can be snared and retrieved back out the femoral artery as they were delivered. Any embolic particles will be captured in the filter device and removed safely from the body.
  • Another method for filtering the carotid arteries would be to deliver a filter from the femoral artery and utilize a single catheter to house the two attachment means to the filters.
  • These attachments may be a wire similar to a guidewire or a hypo-tube to connect the filter element to an external portion of the body. Keeping these wires or connection means organized and contained within a single or dual lumen catheter will help organize and limit potential entanglement with other catheters being delivered to the target site such as the aortic valve or other cardiac elements including but not limited to the mitral valve and coronary arteries.
  • the distal portion of the catheter may have a single exit portion or a staggered exit to allow an exit at different points along the catheter.
  • One exit port may be at the distal most end of the catheter and the other may be a centimeter proximal from this to allow the attachment wire to exit near the left common carotid artery. Furthermore, there could be an extension to the distal most portion of the catheter allowing side ports for both wires to exit. This would allow for additional catheter stabilization within the aorta.
  • Another embodiment would deliver filters to the carotid from the radial artery and allow for a clear aortic arch from catheters and other delivery means from a more conventional femoral delivery means. From this access site a plurality of filters could be delivered through a common access sheath or the filters could be delivered from a dual lumen catheter with each lumen housing a single filter.
  • Another delivery means would utilize a single catheter with filters mounted in a coaxial manner where the distal filter would be delivered first and could be mounted to a wire where the second would be mounted to a hypo-tube where the first filters wire would run through the second allowing for relative motion between the two filters.
  • the first filter would be delivered to the left common carotid from the radial artery and the second would be delivered to the right common carotid artery or the brachiocephalic trunk in a coaxial manner.
  • These filters would be opposed in direction as the distal filter would be filtering blood flowing from the base of the aorta to the head and toward the distal end of the guidewire.
  • the proximal filter would be filtering blood from the base of the aorta to the head and toward the proximal end of the guidewire. Placing the two filters together there would be a conical shape configuration where the large diameter portions of the cones would meet. These two filters would be delivered in a collapsed configuration and expanded when expelled from the delivery catheter. Retrieval would be a retraction of the filter back into a recovery catheter that would be a larger inner diameter than the delivery catheter to allow room for particulate. Being opposed in capture direction the right carotid would be the first filter that would be recovered by an expanded sheath where the embolic material would not be disturbed and further withdrawn to a smaller sheath for removal from the body.
  • the expanded sheath could be constructed from braided Nitinol wire pre-shaped so when exposed the braid would expand to receive the filter without squeezing out any trapped emboli.
  • the second or left carotid filter would be recovered in a conventional manner where the larger diameter would be pulled into a sheath to trap and remove the emboli within the tailor distal portion of the filter.
  • Another means to deliver the filters via radial artery approach would be to utilize a dual lumen catheter where each lumen would house a single filter.
  • the first lumen would deliver a filter to the left carotid artery and the second lumen would deliver a filter to the right carotid artery.
  • the lumens could be staggered in length to reach each ostium in which case the first or left filter lumen would be longer in length to allow for placement distal from the second filter placement in the right carotid.
  • the second lumen may be pre-shaped with a curve to allow easy access to the right carotid artery.
  • This pre-shaped curve may be retained in a straighter manner to allow for delivery and released to express the delivery shape when at the bifurcation of the subclavian and the carotid artery.
  • an active shaping where the curve is directed external to the body by a handle mechanism such as a pull-wire where tension would generate a compressive force to the catheter column preferentially bending the lumen.
  • Recovery could utilize the same dual lumen concept or utilize a second recovery sheath independently from one another.
  • Another application for this device and method would be for surgical operations where the patient may be put on heart-lung bypass.
  • cross clamping of the aorta catheters or wires in the aorta may interfere with the procedure and allow leakage of blood around the cannulas used.
  • additional anti thrombotic coatings to the filter could allow for an extended implantation time allowing filtration time to be extended post procedure.
  • An example of this coating would be Heparin. Placement of these catheters and filters could be under fluoroscopy or ultrasound guidance to direct proper filter placement. Radiopaque markers may add necessary visibility to the catheter, filter and or wires.
  • Another surgical delivery means would be an insertion to the carotid artery via the neck.
  • the filter could face either antigrade or retrograde depending upon the placement insertion point or access site. This would allow for complete filtration without any aortic interference as the entire devices would be within the carotid circulation.
  • the puncture site would be very small and recovery could be through the entry site or through the groin as the filter could be inserted distal to meet a recovery sheath in the aorta. With this groin recovery any emboli within the proximal carotid would be captured before later dislodgement.
  • Intravascular filters have been used in many configurations ranging from a windsock style as commercialized as the FilterWire from Boston Scientific or the ACCUNET from Abbott Vascular or the Spider from eV3. These filters utilize a memory metal such as Nitinol is used to oppose the vascular wall tightly sealing any emboli from passage while a filter material such as a porous fabric material retains and emboli from passing distally from the device.
  • a memory metal such as Nitinol is used to oppose the vascular wall tightly sealing any emboli from passage while a filter material such as a porous fabric material retains and emboli from passing distally from the device.
  • a laser cut memory metal where the basket is the frame and the filter is used to trap emboli when expanded.
  • Another example is constructed from a braided wire such as Medtronic's Interceptor PLUS where once exposed the braid expands to create a funnel or cone shape to trap emboli and the proximal or larger end is pre-shaped to accept blood flow with larger openings heat-set into the memory metal such as Nitinol.
  • These filters range in diameter from about 2-15 mm in diameter and are approximately 20-30 mm in length. They are generally attached to a guidewire and sheathed for delivery and resheathed for recovery. The catheter profile measures about 1 to 2 mm in diameter and has a length of about 90 to 200 cm.
  • Catheter construction is normally a polypropylene or polyethylene material but nylons and blends can be used as well. All devices are considered single use and are commonly placed for carotid stenting or savenous veign grafts stenting.
  • FIG. 1 illustrates the vascular anatomy of the aorta and surrounding great vessels.
  • FIG. 2 illustrates the common technique in carotid filter 8 insertion for carotid stenting 10 as delivered via femoral artery over a guidewire 9 .
  • FIG. 3 illustrates the aortic vasculature where sheaths could be placed by the interventional cardiologist.
  • the right femoral 11 being the most common access as the cardiologist works from the right side of the patient which is presented to the physician while on the table.
  • the right radial artery 12 has been used but due to the small diameter of the vessel is not a common insertion point for the cardiologist.
  • FIG. 4 illustrates a brachial entry with common introducer 13 and guidewire 8 techniques.
  • FIG. 5 illustrates the guide catheter 14 being inserted to the introducer 13 over the guidewire 8 in a brachial artery entry where the guide catheter 14 has a preshaped distal section to access the left common carotid 3 .
  • FIG. 6 illustrates a closer view of the guide catheter 14 and guidewire 8 accessing the left carotid artery where the first filter would be placed.
  • FIG. 7 illustrates the deployment of the first filter 9 through the guide catheter 14 over a guidewire 8 where the filter 9 is fully opposed to the left carotid artery.
  • FIG. 8 illustrates both filters 9 deployed and protecting the carotid arteries utilizing a common guidewire 8 and common guide catheter 14 .
  • FIG. 9 illustrates a dual lumen catheter 29 where each filter 9 has a single guidewire 8 . Both filters 9 are in a conventional orientation where the flow is in the distal direction or toward the distal tip of the guidewire 8 . Independent recovery of the filters 9 could occur or a common recovery sheath may be used to load both into one sheath.
  • FIG. 10 illustrates both filters 9 being delivered via subclavian where the left filter is delivered via left subclavian artery with an entry point in the radial artery.
  • Each delivery would include a guidewire 8 and a guide catheter 14 where a pre-shaped curve would allow access into the respective carotid artery.
  • FIG. 11 illustrates a single organization catheter 15 to retain two filter 9 guidewires 8 controlling the potential for entanglement with each wire or other catheters introduced to the body.
  • catheters would include pigtail catheters used for contrast injections, balloon catheters for dilation or other catheters for delivery of therapeutic agents or implantable devices such as stents or prosthetic heart valves where the catheters are generally larger (18-26 French) in diameter.
  • the catheter would have two distal exit ports to allow each filter to exit at the respective ostia.
  • a distal section would extend beyond the brachiocephalic trunk allowing for a smooth shape to the catheter and ensure it is close to the outer radius of the arch.
  • FIG. 12 illustrates a dual lumen catheter 16 with an active curving mechanism to steer each lumen to the respected carotid artery.
  • the deflection will allow for active steering of each distal section to account for any differences in anatomy from patient to patient.
  • a deflection wire 18 could be tensioned to provide a bias or curve to tip.
  • the delivery of each filter would be in a conventional orientation where the blood flow would be in the distal direction and toward the tip of the guidewire.
  • External to the body would be a handle mechanism 17 providing an actuation force to the distal portion of the catheter.
  • This actuation could be a rotational knob 19 translating a rotation movement to a screw mechanism providing a tension to a wire connected to the catheter tip.
  • Other methods could include an electrical signal to drive a motion or hydraulic actuation to translate a force.
  • FIG. 13 illustrates a filter 9 delivered over the guidewire 8 from the carotid artery in a retrograde approach just short of the aortic arch.
  • FIG. 14 illustrates a set of filters in the carotid arteries delivered and ready for additional procedures to occur under filtered protection.
  • a percutaneous heart valve delivery there maybe multiple catheters in the aortic arch consuming much of the available area. Shown here is a pigtail catheter 22 and a delivery catheter 24 for a percutaneous heart valve 23 all within the aortic arch.
  • the filters 9 are clear of the aortic space and will not interfere with delivery or withdrawal of these catheters.
  • FIG. 15 illustrates another delivery pathway for the placement in the carotid or brachiocephalic trunk.
  • Delivery includes a guidewire 8 introduced via carotid artery or subclavian artery just short of the aortic arch leaving the arch free from interference while delivering other catheters to the heart.
  • These filters 9 can be retrieved either through the groin or recovered back through the entry point in the carotid or subclavian artery.
  • FIG. 16 illustrates a conventional entry to the carotid artery where the sheath is placed in a retrograde manner.
  • a sheath 13 is placed into the carotid artery where access may be gained to the vasculature either anti grade or retrograde depending upon the desired placement of the device.
  • FIG. 17 illustrates an example of a common filter design where the guidewire 8 passes through the central portion of the filter 27 .
  • a memory material such as Nitinol is used to expand the filter material to the vessel wall.
  • FIGS. 18A-B illustrate other examples of filters where a loop style 25 has the guidewire passing along the side of the device and functions like a wind-sox when deployed in the vessel.
  • the other example is a framed filter where when expanded the filter material is opposed to the vessel wall and the guidewire 8 passes through the central portion of the device.
  • a filter would be placed into the carotid arteries to protect the circulation to the brain where emboli could induce a stroke and leave the patient debilitated. Placement of these filters to the patient's carotid circulation would be most convenient if it occurred without obstruction of the aorta where other catheters would be passed and preferably on the patient's right side as it is common practice for the doctor to steer the catheters from this side of the table. Standard practice is to gain access in the right femoral artery where a sheath would be placed to introduce catheters, guidewires and other device delivery means.
  • the final entry point would be an arm entry where a sheath would be placed into the brachial or radial artery for access to the subclavian artery and more distally the aorta and the carotid arteries. This approach would allow the doctor to access the patient's right arm placing a sheath into the radial artery and delivering catheters, guidewires and sheaths to the carotid arteries.
  • a guide catheter After a 5 French sheath placement a guide catheter would be placed into the radial artery and advanced to the brachiocephalic trunk where the right carotid artery meets the subclavian. From here a curve in the guide catheter would allow a 180 turn to occur accessing from the brachiocephalic trunk into the aortic arch and back up the left carotid artery which is commonly found one centimeter down the aortic arch. Once the guide catheter is place a filter may be advanced into the left carotid artery and deployed leaving this vessel protected from emboli.
  • the guide catheter could be moved proximally to leave this vasculature and back into the brachiocephalic trunk artery where a coaxial filter could now be placed protecting this carotid artery.
  • the connection between the two filters is a common axial link where the distal or left carotid filter would be attached to a 0.014 inch guidewire as normally constructed and the more proximal filter would utilize a tubular member such as a polymer or Nitinol hypo tube.
  • the distal filter may need to be gently engaged to the vessel wall to allow the connection guidewire to be tensioned removing any slack or loop within the aortic arch. This may be possible with engagement barbs restricting proximal motion of the device in the vessel when deployed. Other means may be a stronger force in the memory metal loop to keep the device opposed to the wall. Now the circulation to the brain is protected and the aortic arch is clear from obstruction the normal procedure can occur. Examples of these procedures include but are not limited to:
  • the filters may be removed immediately or left in place if an antitrombotic coating is added or the patient remains on blood thinning agents to limit clot from forming on the filters. It may be advantageous to leave the filters in for a period of twenty four hours as the patient begins to recover. When removal is necessary the goal is to not dislodge any trapped emboli within the filter. Conventionally this is accomplished by pulling the filter into a larger recovery sheath to first close the open end of the filter and draw the remaining portion safely back into the recovery catheter. With the filters being opposed in direction it may be advantageous to move the distal filter into the proximal filter and recover them both together in a nested orientation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)
  • Prostheses (AREA)

Abstract

Disclosed is a novel filter and delivery means. The device described within will not interfere with standard practice and tools used during standard surgical procedures and tools such as cannulas, clamps or dissection instruments including valve replacement sizing gages or other surgical procedures where the patient must be put on a heart-lung machine cross-clamping the aorta.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 12/689,997, filed Jan. 19, 2010, which claims priority benefit under 35 U.S.C. §119(e) to U.S. Provisional Application No. 61/145,149, filed Jan. 16, 2009, entitled “Intravascular Blood Filter,” all of which applications are hereby incorporated by reference in their entirety.
  • INCORPORATION BY REFERENCE
  • All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
  • BACKGROUND OF THE INVENTION
  • This invention relates generally to medical devices used during vascular intervention, and more particularly, concerns medical devices that are useful in treating aortic valve replacement, thromboembolic disorders and for removal of foreign bodies in the vascular system.
  • Thromboembolic disorders, such as stroke, pulmonary embolism, peripheral thrombosis, atherosclerosis, and the like, affect many people. These disorders are a major cause of morbidity and mortality in the United States and throughout the world. Thromboembolic events are characterized by an occlusion of a blood vessel. The occlusion can be caused by a clot which is viscoelastic (jelly-like) and is comprised of platelets, fibrinogen, and other clotting proteins.
  • Percutaneous aortic valve replacement has been in development for some time now and stroke rates related to this procedure are between four and twenty percent. During catheter delivery and implantation plaque may be dislodged from the vasculature. The invention contained within will block the emboli from traveling through the carotid circulation and onto the brain. When an artery is occluded by a clot, tissue ischemia (lack of oxygen and nutrients) develops. The ischemia will progress to tissue infarction (cell death) if the occlusion persists. Infarction does not develop or is greatly limited if the flow of blood is reestablished rapidly. Failure to reestablish blood-flow can lead to the loss of limb, angina pectoris, myocardial infarction, stroke, or even death.
  • Occlusion of the venous circulation by thrombi leads to blood stasis which can cause numerous problems. The majority of pulmonary embolisms are caused by emboli that originate in the peripheral venous system. Reestablishing blood flow and removal of the thrombus is highly desirable.
  • There are many existing techniques employed to reestablish blood flow in an occluded vessel. One common surgical technique, an embolectomy, involves incising a blood vessel and introducing a balloon-tipped device (such as a Fogarty catheter) to the location of the occlusion. The balloon is then inflated at a point beyond the clot and used to translate the obstructing material back to the point of incision. The obstructing material is then removed by the surgeon. While such surgical techniques have been useful, exposing a patient to surgery may be traumatic and is best avoided when possible. Additionally, the use of a Fogarty catheter may be problematic due to the possible risk of damaging the interior lining of the vessel as the catheter is being withdrawn.
  • A common percutaneous technique is referred to as balloon angioplasty where a balloon-tipped catheter is introduced into a blood vessel, typically through an introducing catheter. The balloon-tipped catheter is then advanced to the point of the occlusion and inflated in order to dilate the stenosis. Balloon angioplasty is appropriate for treating vessel stenosis but is generally not effective for treating acute thromboembolisms.
  • Another percutaneous technique is to place a microcatheter near the clot and infuse Streptokinase, Urokinase, or other thrombolytic agents to dissolve the clot. Unfortunately, thrombolysis typically takes hours to days to be successful. Additionally, thrombolytic agents can cause hemorrhage and in many patients the agents cannot be used at all.
  • Another problematic area is the removal of foreign bodies. Foreign bodies introduced into the circulation can be fragments of catheters, pace-maker electrodes, guide wires, and erroneously placed embolic material such as thrombogenic coils. There exist retrieval devices for the removal of foreign bodies, certain of such devices form a loop that can ensnare the foreign material by decreasing the size of the diameter of the loop around the foreign body. The use of such removal devices can be difficult and sometimes unsuccessful.
  • Moreover, systems heretofore disclosed in the art are generally limited by size compatibility and the increase in vessel size as the emboli is drawn out from the distal vascular occlusion location to a more proximal location near the heart. If the embolectomy device is too large for the vessel it will not deploy correctly to capture the clot or foreign body, and if too small in diameter it cannot capture clots or foreign bodies across the entire cross section of the blood vessel. Additionally, if the embolectomy device is too small in retaining volume then as the device is retracted the excess material being removed can spill out and be carried by flow back to occlude another distal vessel.
  • Various thrombectomy and foreign matter removal devices have been disclosed in the art. However, such devices have been found to have structures which are either highly complex or lacking in sufficient retaining structure. Disadvantages associated with the devices having highly complex structure include difficulty in manufacturability as well as difficulty in use in conjunction with microcatheters. Recent developments in the removal device art features umbrella filter devices having self folding capabilities. Typically, these filters fold into a pleated condition, wherein the pleats extend radially and can obstruct retraction of the device into the micro catheter sheathing.
  • What has been needed and heretofore unavailable is an extraction device that can be easily and controllably deployed into and retracted from the circulatory system for the effective removal of clots and foreign bodies. There is also a need for a system that can be used as a temporary arterial or venous filter to capture and remove thromboemboli generated during endovascular procedures. Moreover, due to difficult-to-access anatomy such as the cerebral vasculature and the neurovasculature, the invention should possess a small collapsed profile and preferably be expandable to allow the device to be delivered through the lumen of commercially available catheters. The present invention satisfies these needs.
  • SUMMARY OF THE INVENTION
  • Most filter devices are delivered from the groin and are placed distal to the flow of the lesion or site in question. Single basket-type filters or Nitinol loop filters are the most common used today in carotid stent procedures of vein graft stenting. As the guidewire is delivered past the lesion the filter is delivered over the guidewire protecting the distal vasculature. The invention here may be delivered from the groin in a conventional manner to vessels such as the carotid arteries or via radial (arm vasculature) approach. Protecting the carotid arteries and cerebral vasculature system is the main goal while leaving the aortic arch free from catheters and wire as much as possible during the delivery of other devices such as aortic balloons and prosthetic valves or other associated devices.
  • One method of filtering the carotid arteries leaving the aorta free from obstruction is to deliver a filter to each of the carotid arteries from the groin leaving them in the carotid vasculature and retrieving them via snare post procedure. A delivery catheter would be inserted through an introducer in the groin (femoral artery) and delivered to the common carotid arteries and detached. The delivery catheter would be removed and a second filter would be delivered in a similar manner to the other carotid artery. With two detached filters now in place the procedure treating the aortic or mitral valve can now be completed with embolic protection for the cerebral vascular system. Once the procedure to the valve is completed, the filters can be snared and retrieved back out the femoral artery as they were delivered. Any embolic particles will be captured in the filter device and removed safely from the body.
  • Another method for filtering the carotid arteries would be to deliver a filter from the femoral artery and utilize a single catheter to house the two attachment means to the filters. These attachments may be a wire similar to a guidewire or a hypo-tube to connect the filter element to an external portion of the body. Keeping these wires or connection means organized and contained within a single or dual lumen catheter will help organize and limit potential entanglement with other catheters being delivered to the target site such as the aortic valve or other cardiac elements including but not limited to the mitral valve and coronary arteries. The distal portion of the catheter may have a single exit portion or a staggered exit to allow an exit at different points along the catheter. One exit port may be at the distal most end of the catheter and the other may be a centimeter proximal from this to allow the attachment wire to exit near the left common carotid artery. Furthermore, there could be an extension to the distal most portion of the catheter allowing side ports for both wires to exit. This would allow for additional catheter stabilization within the aorta.
  • Another embodiment would deliver filters to the carotid from the radial artery and allow for a clear aortic arch from catheters and other delivery means from a more conventional femoral delivery means. From this access site a plurality of filters could be delivered through a common access sheath or the filters could be delivered from a dual lumen catheter with each lumen housing a single filter.
  • Another delivery means would utilize a single catheter with filters mounted in a coaxial manner where the distal filter would be delivered first and could be mounted to a wire where the second would be mounted to a hypo-tube where the first filters wire would run through the second allowing for relative motion between the two filters. The first filter would be delivered to the left common carotid from the radial artery and the second would be delivered to the right common carotid artery or the brachiocephalic trunk in a coaxial manner. These filters would be opposed in direction as the distal filter would be filtering blood flowing from the base of the aorta to the head and toward the distal end of the guidewire. The proximal filter would be filtering blood from the base of the aorta to the head and toward the proximal end of the guidewire. Placing the two filters together there would be a conical shape configuration where the large diameter portions of the cones would meet. These two filters would be delivered in a collapsed configuration and expanded when expelled from the delivery catheter. Retrieval would be a retraction of the filter back into a recovery catheter that would be a larger inner diameter than the delivery catheter to allow room for particulate. Being opposed in capture direction the right carotid would be the first filter that would be recovered by an expanded sheath where the embolic material would not be disturbed and further withdrawn to a smaller sheath for removal from the body. The expanded sheath could be constructed from braided Nitinol wire pre-shaped so when exposed the braid would expand to receive the filter without squeezing out any trapped emboli. The second or left carotid filter would be recovered in a conventional manner where the larger diameter would be pulled into a sheath to trap and remove the emboli within the tailor distal portion of the filter.
  • Another means to deliver the filters via radial artery approach would be to utilize a dual lumen catheter where each lumen would house a single filter. The first lumen would deliver a filter to the left carotid artery and the second lumen would deliver a filter to the right carotid artery. The lumens could be staggered in length to reach each ostium in which case the first or left filter lumen would be longer in length to allow for placement distal from the second filter placement in the right carotid. Additionally, the second lumen may be pre-shaped with a curve to allow easy access to the right carotid artery. This pre-shaped curve may be retained in a straighter manner to allow for delivery and released to express the delivery shape when at the bifurcation of the subclavian and the carotid artery. Furthermore, there may be an active shaping where the curve is directed external to the body by a handle mechanism such as a pull-wire where tension would generate a compressive force to the catheter column preferentially bending the lumen. Recovery could utilize the same dual lumen concept or utilize a second recovery sheath independently from one another.
  • Another application for this device and method would be for surgical operations where the patient may be put on heart-lung bypass. During cross clamping of the aorta catheters or wires in the aorta may interfere with the procedure and allow leakage of blood around the cannulas used. If any of the above described devices or techniques are used before the patient's chest is opened this filtration of the carotid vessels would protect from emboli thus reducing the stroke risk during and after the procedure. Additional anti thrombotic coatings to the filter could allow for an extended implantation time allowing filtration time to be extended post procedure. An example of this coating would be Heparin. Placement of these catheters and filters could be under fluoroscopy or ultrasound guidance to direct proper filter placement. Radiopaque markers may add necessary visibility to the catheter, filter and or wires.
  • Another surgical delivery means would be an insertion to the carotid artery via the neck. The filter could face either antigrade or retrograde depending upon the placement insertion point or access site. This would allow for complete filtration without any aortic interference as the entire devices would be within the carotid circulation. With this delivery technique the puncture site would be very small and recovery could be through the entry site or through the groin as the filter could be inserted distal to meet a recovery sheath in the aorta. With this groin recovery any emboli within the proximal carotid would be captured before later dislodgement.
  • Intravascular filters have been used in many configurations ranging from a windsock style as commercialized as the FilterWire from Boston Scientific or the ACCUNET from Abbott Vascular or the Spider from eV3. These filters utilize a memory metal such as Nitinol is used to oppose the vascular wall tightly sealing any emboli from passage while a filter material such as a porous fabric material retains and emboli from passing distally from the device. Another example is a laser cut memory metal where the basket is the frame and the filter is used to trap emboli when expanded. Another example is constructed from a braided wire such as Medtronic's Interceptor PLUS where once exposed the braid expands to create a funnel or cone shape to trap emboli and the proximal or larger end is pre-shaped to accept blood flow with larger openings heat-set into the memory metal such as Nitinol. These filters range in diameter from about 2-15 mm in diameter and are approximately 20-30 mm in length. They are generally attached to a guidewire and sheathed for delivery and resheathed for recovery. The catheter profile measures about 1 to 2 mm in diameter and has a length of about 90 to 200 cm. Catheter construction is normally a polypropylene or polyethylene material but nylons and blends can be used as well. All devices are considered single use and are commonly placed for carotid stenting or savenous veign grafts stenting.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates the vascular anatomy of the aorta and surrounding great vessels.
  • FIG. 2 illustrates the common technique in carotid filter 8 insertion for carotid stenting 10 as delivered via femoral artery over a guidewire 9.
  • FIG. 3 illustrates the aortic vasculature where sheaths could be placed by the interventional cardiologist. The right femoral 11 being the most common access as the cardiologist works from the right side of the patient which is presented to the physician while on the table. The right radial artery 12 has been used but due to the small diameter of the vessel is not a common insertion point for the cardiologist.
  • FIG. 4 illustrates a brachial entry with common introducer 13 and guidewire 8 techniques.
  • FIG. 5 illustrates the guide catheter 14 being inserted to the introducer 13 over the guidewire 8 in a brachial artery entry where the guide catheter 14 has a preshaped distal section to access the left common carotid 3.
  • FIG. 6 illustrates a closer view of the guide catheter 14 and guidewire 8 accessing the left carotid artery where the first filter would be placed.
  • FIG. 7 illustrates the deployment of the first filter 9 through the guide catheter 14 over a guidewire 8 where the filter 9 is fully opposed to the left carotid artery.
  • FIG. 8 illustrates both filters 9 deployed and protecting the carotid arteries utilizing a common guidewire 8 and common guide catheter 14.
  • FIG. 9 illustrates a dual lumen catheter 29 where each filter 9 has a single guidewire 8. Both filters 9 are in a conventional orientation where the flow is in the distal direction or toward the distal tip of the guidewire 8. Independent recovery of the filters 9 could occur or a common recovery sheath may be used to load both into one sheath.
  • FIG. 10 illustrates both filters 9 being delivered via subclavian where the left filter is delivered via left subclavian artery with an entry point in the radial artery. Each delivery would include a guidewire 8 and a guide catheter 14 where a pre-shaped curve would allow access into the respective carotid artery.
  • FIG. 11 illustrates a single organization catheter 15 to retain two filter 9 guidewires 8 controlling the potential for entanglement with each wire or other catheters introduced to the body. These catheters would include pigtail catheters used for contrast injections, balloon catheters for dilation or other catheters for delivery of therapeutic agents or implantable devices such as stents or prosthetic heart valves where the catheters are generally larger (18-26 French) in diameter. The catheter would have two distal exit ports to allow each filter to exit at the respective ostia. A distal section would extend beyond the brachiocephalic trunk allowing for a smooth shape to the catheter and ensure it is close to the outer radius of the arch.
  • FIG. 12 illustrates a dual lumen catheter 16 with an active curving mechanism to steer each lumen to the respected carotid artery. The deflection will allow for active steering of each distal section to account for any differences in anatomy from patient to patient. Similar to electrophysiology catheters a deflection wire 18 could be tensioned to provide a bias or curve to tip. The delivery of each filter would be in a conventional orientation where the blood flow would be in the distal direction and toward the tip of the guidewire. External to the body would be a handle mechanism 17 providing an actuation force to the distal portion of the catheter. This actuation could be a rotational knob 19 translating a rotation movement to a screw mechanism providing a tension to a wire connected to the catheter tip. Other methods could include an electrical signal to drive a motion or hydraulic actuation to translate a force.
  • FIG. 13 illustrates a filter 9 delivered over the guidewire 8 from the carotid artery in a retrograde approach just short of the aortic arch. Once the procedure is completed the filter can be snared with a conventional snare 20 to remove it from the body. This will allow for a very small (0.03 inch) entry port in the neck to introduce the device and a larger recovery sheath 21 in the groin where other devices are introduced.
  • FIG. 14 illustrates a set of filters in the carotid arteries delivered and ready for additional procedures to occur under filtered protection. During a percutaneous heart valve delivery there maybe multiple catheters in the aortic arch consuming much of the available area. Shown here is a pigtail catheter 22 and a delivery catheter 24 for a percutaneous heart valve 23 all within the aortic arch. The filters 9 are clear of the aortic space and will not interfere with delivery or withdrawal of these catheters.
  • FIG. 15 illustrates another delivery pathway for the placement in the carotid or brachiocephalic trunk. Delivery includes a guidewire 8 introduced via carotid artery or subclavian artery just short of the aortic arch leaving the arch free from interference while delivering other catheters to the heart. These filters 9 can be retrieved either through the groin or recovered back through the entry point in the carotid or subclavian artery.
  • FIG. 16 illustrates a conventional entry to the carotid artery where the sheath is placed in a retrograde manner. A sheath 13 is placed into the carotid artery where access may be gained to the vasculature either anti grade or retrograde depending upon the desired placement of the device.
  • FIG. 17 illustrates an example of a common filter design where the guidewire 8 passes through the central portion of the filter 27. A memory material such as Nitinol is used to expand the filter material to the vessel wall.
  • FIGS. 18A-B illustrate other examples of filters where a loop style 25 has the guidewire passing along the side of the device and functions like a wind-sox when deployed in the vessel. The other example is a framed filter where when expanded the filter material is opposed to the vessel wall and the guidewire 8 passes through the central portion of the device.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • Before standard intervention would occur by a cardiologist a filter would be placed into the carotid arteries to protect the circulation to the brain where emboli could induce a stroke and leave the patient debilitated. Placement of these filters to the patient's carotid circulation would be most convenient if it occurred without obstruction of the aorta where other catheters would be passed and preferably on the patient's right side as it is common practice for the doctor to steer the catheters from this side of the table. Standard practice is to gain access in the right femoral artery where a sheath would be placed to introduce catheters, guidewires and other device delivery means. This would leave the left femoral artery open but often it too is used for other diagnostic catheters and it is less convenient to work across the patient's body. Other access sites would include carotid entry but the neck area is often again inconvenient to operate from and generally too far from the other wires and catheters. The final entry point would be an arm entry where a sheath would be placed into the brachial or radial artery for access to the subclavian artery and more distally the aorta and the carotid arteries. This approach would allow the doctor to access the patient's right arm placing a sheath into the radial artery and delivering catheters, guidewires and sheaths to the carotid arteries. After a 5 French sheath placement a guide catheter would be placed into the radial artery and advanced to the brachiocephalic trunk where the right carotid artery meets the subclavian. From here a curve in the guide catheter would allow a 180 turn to occur accessing from the brachiocephalic trunk into the aortic arch and back up the left carotid artery which is commonly found one centimeter down the aortic arch. Once the guide catheter is place a filter may be advanced into the left carotid artery and deployed leaving this vessel protected from emboli. The guide catheter could be moved proximally to leave this vasculature and back into the brachiocephalic trunk artery where a coaxial filter could now be placed protecting this carotid artery. The connection between the two filters is a common axial link where the distal or left carotid filter would be attached to a 0.014 inch guidewire as normally constructed and the more proximal filter would utilize a tubular member such as a polymer or Nitinol hypo tube. The distal filter may need to be gently engaged to the vessel wall to allow the connection guidewire to be tensioned removing any slack or loop within the aortic arch. This may be possible with engagement barbs restricting proximal motion of the device in the vessel when deployed. Other means may be a stronger force in the memory metal loop to keep the device opposed to the wall. Now the circulation to the brain is protected and the aortic arch is clear from obstruction the normal procedure can occur. Examples of these procedures include but are not limited to:
      • Coronary stenting
      • Aortic valve replacement via catheterization
      • Aortic or mitral valve replacement via transapical
      • Aortic balloon valvuloplasty
      • Mitral valvuloplasty
      • Mitral valve replacement via catheterization
      • Diagnostic catheterization
      • Surgical valve replacement (aortic or mitral)
      • Surgical valve repair (aortic or mitral)
      • Annuloplasty ring placement
      • Atrial fibrillation catheterization
      • PFO closure (surgical or catheter based)
      • Left atrial appendage closure (catheter or surgical)
  • Once the procedure has been completed the filters may be removed immediately or left in place if an antitrombotic coating is added or the patient remains on blood thinning agents to limit clot from forming on the filters. It may be advantageous to leave the filters in for a period of twenty four hours as the patient begins to recover. When removal is necessary the goal is to not dislodge any trapped emboli within the filter. Conventionally this is accomplished by pulling the filter into a larger recovery sheath to first close the open end of the filter and draw the remaining portion safely back into the recovery catheter. With the filters being opposed in direction it may be advantageous to move the distal filter into the proximal filter and recover them both together in a nested orientation.

Claims (15)

1-8. (canceled)
9. A filter system comprising:
a first tubular member and a second tubular member;
a first filter mounted on the first tubular member, the first filter configured to move between a collapsed configuration and an expanded configuration; and
a second filter mounted on the second tubular member, the second filter configured to move between a collapsed configuration and an expanded configuration,
wherein the first tubular member and the second tubular member are coaxially disposed and configured to move relative to each other to provide relative motion between the first filter and the second filter.
10. The filter system of claim 9, wherein the first filter and the second filter are positioned in opposing directions.
11. The filter system of claim 9, wherein the first tubular member is coaxially disposed within the second tubular member.
12. The filter system of claim 11, wherein the first filter is configured to be positioned distal to the second filter.
13. The filter system of claim 9, further comprising a handle having an actuation member, the actuation member configured to actively and controllably shape a distal end of the first tubular member.
14. The filter system of claim 13, wherein the actuation member is configured to apply tension to the distal end of the first tubular member through a pull wire.
15. A method of filtering a subject's blood, comprising the steps of:
providing a delivery catheter having a shapeable distal end;
inserting the delivery catheter into a first vessel;
advancing the delivery catheter through the vessel toward and proximate a second vessel;
actively and controllably shaping the distal end of the delivery catheter to access the second vessel;
advancing a filter in a collapsed configuration through the delivery catheter and into the second vessel; and
expanding the filter such that the filter is introduced into the second vessel in the collapsed configuration and expanded in the second vessel.
16. The method of claim 15 further comprising the step of providing a wire element to which the filter is mounted.
17. The method of claim 15 further comprising the step of providing a tubular member to which the filter is mounted.
18. The method of claim 15 further comprising the step of selecting the first vessel from the group of vessels consisting of: the radial artery; the brachial artery; the carotid artery; and the femoral artery.
19. The method of claim 18 further comprising the step of selecting the second vessel from the group of vessels consisting of: the right common carotid artery; the left common carotid artery; and the left subclavian artery.
20. The method of claim 15, wherein actively and controllably shaping the distal end of the delivery catheter comprises actuating an actuation member on a handle positioned external to the subject.
21. The method of claim 15, wherein actively and controllably shaping the distal end of the delivery catheter comprises applying tension to a distal end of the delivery catheter through a pull wire.
22. The method of claim 15, wherein inserting the delivery catheter comprises advancing the delivery catheter over a guidewire.
US13/738,847 2009-01-16 2013-01-10 Intravascular blood filter Abandoned US20130231694A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/738,847 US20130231694A1 (en) 2009-01-16 2013-01-10 Intravascular blood filter
US15/838,949 US10743977B2 (en) 2009-01-16 2017-12-12 Intravascular blood filter
US16/934,962 US11364106B2 (en) 2009-01-16 2020-07-21 Intravascular blood filter
US17/752,209 US12048618B2 (en) 2009-01-16 2022-05-24 Intravascular blood filter

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14514909P 2009-01-16 2009-01-16
US12/689,997 US8372108B2 (en) 2009-01-16 2010-01-19 Intravascular blood filter
US13/738,847 US20130231694A1 (en) 2009-01-16 2013-01-10 Intravascular blood filter

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/689,997 Continuation US8372108B2 (en) 2009-01-16 2010-01-19 Intravascular blood filter

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/838,949 Continuation US10743977B2 (en) 2009-01-16 2017-12-12 Intravascular blood filter

Publications (1)

Publication Number Publication Date
US20130231694A1 true US20130231694A1 (en) 2013-09-05

Family

ID=42337545

Family Applications (5)

Application Number Title Priority Date Filing Date
US12/689,997 Active 2031-03-07 US8372108B2 (en) 2009-01-16 2010-01-19 Intravascular blood filter
US13/738,847 Abandoned US20130231694A1 (en) 2009-01-16 2013-01-10 Intravascular blood filter
US15/838,949 Active 2030-11-05 US10743977B2 (en) 2009-01-16 2017-12-12 Intravascular blood filter
US16/934,962 Active US11364106B2 (en) 2009-01-16 2020-07-21 Intravascular blood filter
US17/752,209 Active 2030-05-18 US12048618B2 (en) 2009-01-16 2022-05-24 Intravascular blood filter

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/689,997 Active 2031-03-07 US8372108B2 (en) 2009-01-16 2010-01-19 Intravascular blood filter

Family Applications After (3)

Application Number Title Priority Date Filing Date
US15/838,949 Active 2030-11-05 US10743977B2 (en) 2009-01-16 2017-12-12 Intravascular blood filter
US16/934,962 Active US11364106B2 (en) 2009-01-16 2020-07-21 Intravascular blood filter
US17/752,209 Active 2030-05-18 US12048618B2 (en) 2009-01-16 2022-05-24 Intravascular blood filter

Country Status (4)

Country Link
US (5) US8372108B2 (en)
EP (1) EP2387427B1 (en)
ES (1) ES2516066T3 (en)
WO (1) WO2010083527A2 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8753370B2 (en) 2009-07-27 2014-06-17 Claret Medical, Inc. Dual endovascular filter and methods of use
US8876796B2 (en) 2010-12-30 2014-11-04 Claret Medical, Inc. Method of accessing the left common carotid artery
US9326843B2 (en) 2009-01-16 2016-05-03 Claret Medical, Inc. Intravascular blood filters and methods of use
US9566144B2 (en) 2015-04-22 2017-02-14 Claret Medical, Inc. Vascular filters, deflectors, and methods
US9636205B2 (en) 2009-01-16 2017-05-02 Claret Medical, Inc. Intravascular blood filters and methods of use
US10314600B2 (en) 2012-05-21 2019-06-11 Noha, Llc Clot removal device and method of using same
US10743977B2 (en) 2009-01-16 2020-08-18 Boston Scientific Scimed, Inc. Intravascular blood filter
US11154390B2 (en) 2017-12-19 2021-10-26 Claret Medical, Inc. Systems for protection of the cerebral vasculature during a cardiac procedure
US11191630B2 (en) 2017-10-27 2021-12-07 Claret Medical, Inc. Systems and methods for protecting the cerebral vasculature
US11337790B2 (en) 2017-02-22 2022-05-24 Boston Scientific Scimed, Inc. Systems and methods for protecting the cerebral vasculature
US11351023B2 (en) 2018-08-21 2022-06-07 Claret Medical, Inc. Systems and methods for protecting the cerebral vasculature
US11439491B2 (en) 2018-04-26 2022-09-13 Claret Medical, Inc. Systems and methods for protecting the cerebral vasculature
US11607301B2 (en) 2009-01-16 2023-03-21 Boston Scientific Scimed, Inc. Intravascular blood filters and methods of use

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9510930B2 (en) 2008-10-22 2016-12-06 Contego Medical, Llc Angioplasty device with embolic filter
US9707071B2 (en) 2004-11-24 2017-07-18 Contego Medical Llc Percutaneous transluminal angioplasty device with integral embolic filter
JP5762955B2 (en) 2008-06-23 2015-08-12 ルーメン・バイオメディカル・インコーポレイテッドLumen Biomedical, Inc. Embolization prevention during percutaneous heart valve replacement and similar procedures
WO2010088520A2 (en) 2009-01-29 2010-08-05 Claret Medical, Inc. Illuminated intravascular blood filter
US20120203265A1 (en) * 2010-10-14 2012-08-09 Heuser Richard R Embolism protection device
US9744023B2 (en) 2011-10-25 2017-08-29 Boston Scientific Scimed, Inc. Embolic debris deflector
US8968354B2 (en) 2011-10-26 2015-03-03 Boston Scientific Scimed, Inc. Extended protection embolic filter
US10426501B2 (en) 2012-01-13 2019-10-01 Crux Biomedical, Inc. Retrieval snare device and method
US10548706B2 (en) 2012-01-13 2020-02-04 Volcano Corporation Retrieval snare device and method
WO2013109623A1 (en) 2012-01-17 2013-07-25 Lumen Biomedical, Inc. Aortic arch filtration system for carotid artery protection
US10213187B1 (en) 2012-01-25 2019-02-26 Mubin I. Syed Method and apparatus for percutaneous superficial temporal artery access for carotid artery stenting
US10213288B2 (en) 2012-03-06 2019-02-26 Crux Biomedical, Inc. Distal protection filter
WO2013154765A2 (en) 2012-04-13 2013-10-17 Regents Of The University Of Minnesota Cardio-embolic stroke prevention
US10639179B2 (en) 2012-11-21 2020-05-05 Ram Medical Innovations, Llc System for the intravascular placement of a medical device
US9186238B2 (en) * 2013-01-29 2015-11-17 St. Jude Medical, Cardiology Division, Inc. Aortic great vessel protection
US9968434B2 (en) * 2013-06-10 2018-05-15 Subbarao V. Myla Methods and devices for embolic protection
US10350098B2 (en) 2013-12-20 2019-07-16 Volcano Corporation Devices and methods for controlled endoluminal filter deployment
ES2968797T3 (en) 2015-01-23 2024-05-14 Contego Medical Inc Intervention device with an integrated embolic filter
US9636244B2 (en) 2015-04-09 2017-05-02 Mubin I. Syed Apparatus and method for proximal to distal stent deployment
EP3288492B1 (en) 2015-04-30 2024-10-16 EmStop Inc. System for implanting a prosthetic aortic valve and an embolic material blocking catheter
WO2017002155A1 (en) 2015-06-29 2017-01-05 アクセスポイントテクノロジーズ有限会社 Emboli capture device
US10779976B2 (en) 2015-10-30 2020-09-22 Ram Medical Innovations, Llc Apparatus and method for stabilization of procedural catheter in tortuous vessels
US10492936B2 (en) 2015-10-30 2019-12-03 Ram Medical Innovations, Llc Apparatus and method for improved access of procedural catheter in tortuous vessels
US9980838B2 (en) 2015-10-30 2018-05-29 Ram Medical Innovations Llc Apparatus and method for a bifurcated catheter for use in hostile aortic arches
US11020256B2 (en) 2015-10-30 2021-06-01 Ram Medical Innovations, Inc. Bifurcated “Y” anchor support for coronary interventions
US10327929B2 (en) 2015-10-30 2019-06-25 Ram Medical Innovations, Llc Apparatus and method for stabilization of procedural catheter in tortuous vessels
US10173031B2 (en) 2016-06-20 2019-01-08 Mubin I. Syed Interchangeable flush/selective catheter
US10456252B2 (en) * 2016-08-31 2019-10-29 Medtronic Vascular, Inc. Transcatheter guidewire delivery systems, catheter assemblies for guidewire delivery, and methods for percutaneous guidewire delivery across heart valves
EP3585305A1 (en) 2017-02-23 2020-01-01 Boston Scientific Scimed, Inc. Medical drain device
US11134967B2 (en) * 2017-12-13 2021-10-05 Eric Raul GUERRA Thrombectomy catheter and methods of use
US11229451B2 (en) 2017-12-13 2022-01-25 Eric Raul GUERRA Thrombectomy catheter and methods of use
CN111902105B (en) 2017-12-28 2023-08-01 艾姆斯托普股份有限公司 Embolic material trapping catheters and related devices and methods
US10857014B2 (en) 2018-02-18 2020-12-08 Ram Medical Innovations, Llc Modified fixed flat wire bifurcated catheter and its application in lower extremity interventions
US11389284B2 (en) 2018-09-28 2022-07-19 Boston Scientific Scimed, Inc. Embolic protection devices
US10828038B2 (en) 2018-10-05 2020-11-10 Lakshmikumar Pillai, MD Carotid artery embolic protection method using percutaneous transjugular carotid flow reversal
EP3893981A4 (en) * 2018-12-15 2022-08-10 Guerra, Eric Raul Thrombectomy catheter and methods of use
US11426173B2 (en) 2019-01-04 2022-08-30 Lakshmikumar Pillai Devices and methods using percutaneous transjugular carotid flow reversal
EP3718505A1 (en) 2019-04-05 2020-10-07 Aorticlab Sarl Transcatheter anti embolic filter for arterial and venous vessels
US11051928B2 (en) 2019-04-11 2021-07-06 Neuravi Limited Floating carotid filter
US10835258B1 (en) 2019-08-21 2020-11-17 Lakshmikumar Pillai Systems and methods for retrograde perfusion and clearance of emboli
US12042152B2 (en) 2019-08-21 2024-07-23 Lakshmikumar Pillai Systems and methods for retrograde perfusion and clearance of emboli
IT202100006239A1 (en) 2021-03-16 2022-09-16 Violatech Srl EMBOLIC PROTECTIVE DEVICE
CN114569284B (en) * 2022-03-29 2024-03-15 上海以心医疗器械有限公司 Brain protection device

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375628B1 (en) * 1997-03-06 2002-04-23 Medtronic Percusurge, Inc. Hollow medical wires and methods of constructing same
US20020072764A1 (en) * 2000-06-29 2002-06-13 Concentric Medical, Inc. Systems, method and devices for removing obstructions from a blood vessel
US20060100658A1 (en) * 2004-11-09 2006-05-11 Hiroyuki Obana Interventional guiding sheath system and method of use
US20060135961A1 (en) * 2004-12-17 2006-06-22 Biocardia, Inc. Steerable guide catheters and methods for their use
US20070005131A1 (en) * 2005-06-13 2007-01-04 Taylor David M Heart valve delivery system
US20070043259A1 (en) * 2000-04-03 2007-02-22 Ross Jaffe Endoscope Having a Guide Tube
US20080275485A1 (en) * 2006-04-03 2008-11-06 Possis Medical, Inc. Guidewire with collapsible filter system and method of use
US20090326575A1 (en) * 2008-06-23 2009-12-31 Galdonik Jason A Embolic protection during percutaneous heart valve replacement and similar procedures

Family Cites Families (229)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472230A (en) * 1966-12-19 1969-10-14 Fogarty T J Umbrella catheter
US4630609A (en) 1981-05-14 1986-12-23 Thomas J. Fogarty Dilatation catheter method and apparatus
DK151404C (en) * 1984-05-23 1988-07-18 Cook Europ Aps William FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD
US4706671A (en) * 1985-05-02 1987-11-17 Weinrib Harry P Catheter with coiled tip
US4650466A (en) * 1985-11-01 1987-03-17 Angiobrade Partners Angioplasty device
US4723549A (en) * 1986-09-18 1988-02-09 Wholey Mark H Method and apparatus for dilating blood vessels
US4873978A (en) * 1987-12-04 1989-10-17 Robert Ginsburg Device and method for emboli retrieval
US5254088A (en) 1990-02-02 1993-10-19 Ep Technologies, Inc. Catheter steering mechanism
DK0516730T4 (en) 1990-02-20 2001-01-08 Procter & Gamble Open capillary canal structures, improved method of making capillary canal structures, and extrusion mold for use
US5108419A (en) * 1990-08-16 1992-04-28 Evi Corporation Endovascular filter and method for use thereof
US5348545A (en) 1990-08-21 1994-09-20 Advanced Cardiovascular Systems, Inc. Guiding catheter for the right coronary artery
US5329923A (en) 1991-02-15 1994-07-19 Lundquist Ingemar H Torquable catheter
US5304131A (en) 1991-07-15 1994-04-19 Paskar Larry D Catheter
US5766151A (en) * 1991-07-16 1998-06-16 Heartport, Inc. Endovascular system for arresting the heart
US5192286A (en) * 1991-07-26 1993-03-09 Regents Of The University Of California Method and device for retrieving materials from body lumens
WO1993013704A1 (en) 1992-01-09 1993-07-22 Endomedix Corporation Bi-directional miniscope
CA2173118C (en) 1993-10-01 2000-09-26 Hannah S. Kim Improved vena cava filter
WO1996001591A1 (en) * 1994-07-08 1996-01-25 Microvena Corporation Method of forming medical devices; intravascular occlusion devices
US5624430A (en) 1994-11-28 1997-04-29 Eton; Darwin Magnetic device to assist transcorporeal guidewire placement
US5613980A (en) * 1994-12-22 1997-03-25 Chauhan; Tusharsindhu C. Bifurcated catheter system and method
US5680873A (en) 1995-03-02 1997-10-28 Scimed Life Systems, Inc. Braidless guide catheter
US5833650A (en) 1995-06-05 1998-11-10 Percusurge, Inc. Catheter apparatus and method for treating occluded vessels
US5707389A (en) * 1995-06-07 1998-01-13 Baxter International Inc. Side branch occlusion catheter device having integrated endoscope for performing endoscopically visualized occlusion of the side branches of an anatomical passageway
US6264663B1 (en) * 1995-10-06 2001-07-24 Metamorphic Surgical Devices, Llc Device for removing solid objects from body canals, cavities and organs including an invertable basket
US5779716A (en) * 1995-10-06 1998-07-14 Metamorphic Surgical Devices, Inc. Device for removing solid objects from body canals, cavities and organs
US5769816A (en) * 1995-11-07 1998-06-23 Embol-X, Inc. Cannula with associated filter
US5989281A (en) 1995-11-07 1999-11-23 Embol-X, Inc. Cannula with associated filter and methods of use during cardiac surgery
US6096053A (en) * 1996-05-03 2000-08-01 Scimed Life Systems, Inc. Medical retrieval basket
US5935139A (en) * 1996-05-03 1999-08-10 Boston Scientific Corporation System for immobilizing or manipulating an object in a tract
US6048331A (en) 1996-05-14 2000-04-11 Embol-X, Inc. Cardioplegia occluder
US20050245894A1 (en) 1996-05-20 2005-11-03 Medtronic Vascular, Inc. Methods and apparatuses for drug delivery to an intravascular occlusion
US5910364A (en) 1996-07-10 1999-06-08 Asahi Intecc Co., Ltd. Guide wire and a method of making the same
US5662671A (en) 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US5827324A (en) * 1997-03-06 1998-10-27 Scimed Life Systems, Inc. Distal protection device
US5814064A (en) * 1997-03-06 1998-09-29 Scimed Life Systems, Inc. Distal protection device
US20020026145A1 (en) 1997-03-06 2002-02-28 Bagaoisan Celso J. Method and apparatus for emboli containment
US7094249B1 (en) * 1997-03-06 2006-08-22 Boston Scientific Scimed, Inc. Distal protection device and method
EP0934092A4 (en) 1997-03-06 2008-03-26 Boston Scient Scimed Inc Distal protection device and method
US6152946A (en) * 1998-03-05 2000-11-28 Scimed Life Systems, Inc. Distal protection device and method
US6676682B1 (en) * 1997-05-08 2004-01-13 Scimed Life Systems, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US5911734A (en) * 1997-05-08 1999-06-15 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US6258120B1 (en) * 1997-12-23 2001-07-10 Embol-X, Inc. Implantable cerebral protection device and methods of use
US5848964A (en) 1997-06-06 1998-12-15 Samuels; Shaun Lawrence Wilkie Temporary inflatable filter device and method of use
US6245088B1 (en) * 1997-07-07 2001-06-12 Samuel R. Lowery Retrievable umbrella sieve and method of use
US7569066B2 (en) 1997-07-10 2009-08-04 Boston Scientific Scimed, Inc. Methods and devices for the treatment of aneurysms
US6063070A (en) 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
US5897529A (en) 1997-09-05 1999-04-27 Cordis Webster, Inc. Steerable deflectable catheter having improved flexibility
US6361545B1 (en) 1997-09-26 2002-03-26 Cardeon Corporation Perfusion filter catheter
US6066149A (en) 1997-09-30 2000-05-23 Target Therapeutics, Inc. Mechanical clot treatment device with distal filter
US6099534A (en) 1997-10-01 2000-08-08 Scimed Life Systems, Inc. Releasable basket
IE980920A1 (en) * 1997-11-07 1999-05-19 Salviac Ltd An embolic protection device
US6159178A (en) 1998-01-23 2000-12-12 Heartport, Inc. Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested
US6530902B1 (en) 1998-01-23 2003-03-11 Medtronic, Inc. Cannula placement system
US6423032B2 (en) * 1998-03-13 2002-07-23 Arteria Medical Science, Inc. Apparatus and methods for reducing embolization during treatment of carotid artery disease
US6045547A (en) 1998-06-15 2000-04-04 Scimed Life Systems, Inc. Semi-continuous co-extruded catheter shaft
IL124958A0 (en) 1998-06-16 1999-01-26 Yodfat Ofer Implantable blood filtering device
US6336116B1 (en) 1998-08-06 2002-01-01 Ryan Brown Search and index hosting system
US6726651B1 (en) 1999-08-04 2004-04-27 Cardeon Corporation Method and apparatus for differentially perfusing a patient during cardiopulmonary bypass
US6440120B1 (en) 1998-09-02 2002-08-27 Embol-X, Inc. Bendable shape-retaining cannula
US6342062B1 (en) 1998-09-24 2002-01-29 Scimed Life Systems, Inc. Retrieval devices for vena cava filter
US6051014A (en) 1998-10-13 2000-04-18 Embol-X, Inc. Percutaneous filtration catheter for valve repair surgery and methods of use
US6080140A (en) 1998-11-04 2000-06-27 Iowa-India Investments Company, Ltd. Integral cerebro-vascular access system
US6083239A (en) * 1998-11-24 2000-07-04 Embol-X, Inc. Compliant framework and methods of use
US6161547A (en) * 1999-01-15 2000-12-19 Coaxia, Inc. Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use
US6896690B1 (en) 2000-01-27 2005-05-24 Viacor, Inc. Cardiac valve procedure methods and devices
US6991641B2 (en) 1999-02-12 2006-01-31 Cordis Corporation Low profile vascular filter system
US20020138094A1 (en) 1999-02-12 2002-09-26 Thomas Borillo Vascular filter system
US6146396A (en) 1999-03-05 2000-11-14 Board Of Regents, The University Of Texas System Declotting method and apparatus
US6277138B1 (en) 1999-08-17 2001-08-21 Scion Cardio-Vascular, Inc. Filter for embolic material mounted on expandable frame
US20040044350A1 (en) 1999-04-09 2004-03-04 Evalve, Inc. Steerable access sheath and methods of use
US6267776B1 (en) 1999-05-03 2001-07-31 O'connell Paul T. Vena cava filter and method for treating pulmonary embolism
US7037320B2 (en) 2001-12-21 2006-05-02 Salviac Limited Support frame for an embolic protection device
US6964672B2 (en) 1999-05-07 2005-11-15 Salviac Limited Support frame for an embolic protection device
WO2000067670A1 (en) * 1999-05-07 2000-11-16 Salviac Limited An embolic protection device
US7637905B2 (en) 2003-01-15 2009-12-29 Usgi Medical, Inc. Endoluminal tool deployment system
US6364900B1 (en) 1999-07-14 2002-04-02 Richard R. Heuser Embolism prevention device
WO2001008743A1 (en) 1999-07-30 2001-02-08 Incept Llc Vascular device for emboli, thrombus and foreign body removal and methods of use
US6544279B1 (en) * 2000-08-09 2003-04-08 Incept, Llc Vascular device for emboli, thrombus and foreign body removal and methods of use
US6203561B1 (en) 1999-07-30 2001-03-20 Incept Llc Integrated vascular device having thrombectomy element and vascular filter and methods of use
US7306618B2 (en) * 1999-07-30 2007-12-11 Incept Llc Vascular device for emboli and thrombi removal and methods of use
US6589263B1 (en) 1999-07-30 2003-07-08 Incept Llc Vascular device having one or more articulation regions and methods of use
US6616679B1 (en) 1999-07-30 2003-09-09 Incept, Llc Rapid exchange vascular device for emboli and thrombus removal and methods of use
US6371970B1 (en) 1999-07-30 2002-04-16 Incept Llc Vascular filter having articulation region and methods of use in the ascending aorta
US6214026B1 (en) 1999-07-30 2001-04-10 Incept Llc Delivery system for a vascular device with articulation region
US6620182B1 (en) 1999-07-30 2003-09-16 Incept Llc Vascular filter having articulation region and methods of use in the ascending aorta
US6530939B1 (en) 1999-07-30 2003-03-11 Incept, Llc Vascular device having articulation region and methods of use
US6179861B1 (en) 1999-07-30 2001-01-30 Incept Llc Vascular device having one or more articulation regions and methods of use
US20020022858A1 (en) 1999-07-30 2002-02-21 Demond Jackson F. Vascular device for emboli removal having suspension strut and methods of use
AU6614900A (en) 1999-07-30 2001-02-19 Incept Llc Vascular filter having articulation region and methods of use in the ascending aorta
US6142987A (en) * 1999-08-03 2000-11-07 Scimed Life Systems, Inc. Guided filter with support wire and methods of use
US6245087B1 (en) 1999-08-03 2001-06-12 Embol-X, Inc. Variable expansion frame system for deploying medical devices and methods of use
US6346116B1 (en) * 1999-08-03 2002-02-12 Medtronic Ave, Inc. Distal protection device
US6168579B1 (en) 1999-08-04 2001-01-02 Scimed Life Systems, Inc. Filter flush system and methods of use
AU5796899A (en) * 1999-08-27 2001-03-26 Microvena Corporation Slideable vascular filter
US6325815B1 (en) 1999-09-21 2001-12-04 Microvena Corporation Temporary vascular filter
US6171328B1 (en) * 1999-11-09 2001-01-09 Embol-X, Inc. Intravascular catheter filter with interlocking petal design and methods of use
US6371971B1 (en) * 1999-11-15 2002-04-16 Scimed Life Systems, Inc. Guidewire filter and methods of use
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
JP3426174B2 (en) 1999-12-24 2003-07-14 朝日インテック株式会社 Medical guidewire
US6290710B1 (en) 1999-12-29 2001-09-18 Advanced Cardiovascular Systems, Inc. Embolic protection device
US6485502B2 (en) * 2000-03-10 2002-11-26 T. Anthony Don Michael Vascular embolism prevention device employing filters
US6719717B1 (en) 2000-03-17 2004-04-13 Advanced Research & Technology Institute, Inc. Thrombectomy treatment system and method
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US6740061B1 (en) * 2000-07-28 2004-05-25 Ev3 Inc. Distal protection device
US6482221B1 (en) 2000-08-21 2002-11-19 Counter Clockwise, Inc. Manipulatable delivery catheter for occlusive devices (II)
DE10047421C1 (en) 2000-09-26 2003-01-02 Klaus Sodemann Method and device for ultrafiltration control in blood treatment methods
DE10049812B4 (en) 2000-10-09 2004-06-03 Universitätsklinikum Freiburg Device for filtering out macroscopic particles from the bloodstream during local removal of an aortic valve on the human or animal heart
JP2004517652A (en) * 2000-10-18 2004-06-17 エヌエムティー メディカル インコーポレイテッド Interlock installation / separation mechanism over wire
US6595983B2 (en) 2000-12-07 2003-07-22 Jan K. Voda Guide or diagnostic catheter for right coronary artery
US7169165B2 (en) * 2001-01-16 2007-01-30 Boston Scientific Scimed, Inc. Rapid exchange sheath for deployment of medical devices and methods of use
US6663651B2 (en) 2001-01-16 2003-12-16 Incept Llc Systems and methods for vascular filter retrieval
US7011094B2 (en) 2001-03-02 2006-03-14 Emphasys Medical, Inc. Bronchial flow control devices and methods of use
US7806906B2 (en) * 2001-03-12 2010-10-05 Don Michael T Anthony Vascular filter with improved strength and flexibility
US7214237B2 (en) * 2001-03-12 2007-05-08 Don Michael T Anthony Vascular filter with improved strength and flexibility
US20040243175A1 (en) 2001-03-12 2004-12-02 Don Michael T. Anthony Vascular obstruction removal system and method
US6881194B2 (en) 2001-03-21 2005-04-19 Asahi Intec Co., Ltd. Wire-stranded medical hollow tube, and a medical guide wire
JP3734717B2 (en) 2001-04-26 2006-01-11 富士通株式会社 Image sensor
US6830579B2 (en) * 2001-05-01 2004-12-14 Coaxia, Inc. Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature
US6997939B2 (en) 2001-07-02 2006-02-14 Rubicon Medical, Inc. Methods, systems, and devices for deploying an embolic protection filter
US7160255B2 (en) * 2001-07-12 2007-01-09 Vahid Saadat Method and device for sensing and mapping temperature profile of a hollow body organ
US7169161B2 (en) 2001-11-06 2007-01-30 Possis Medical, Inc. Guidewire having occlusive device and repeatably crimpable proximal end
US6817999B2 (en) 2002-01-03 2004-11-16 Afx, Inc. Flexible device for ablation of biological tissue
US6958074B2 (en) 2002-01-07 2005-10-25 Cordis Corporation Releasable and retrievable vascular filter system
US6907298B2 (en) 2002-01-09 2005-06-14 Medtronic, Inc. Method and apparatus for imparting curves in implantable elongated medical instruments
US20030144686A1 (en) 2002-01-30 2003-07-31 Embol-X, Inc. Distal filtration devices and methods of use during aortic procedures
ES2295608T3 (en) 2002-03-05 2008-04-16 Salviac Limited SYSTEM WITH EMBOLIC FILTER AND RETRACTABLE HANDLE.
US6773448B2 (en) * 2002-03-08 2004-08-10 Ev3 Inc. Distal protection devices having controllable wire motion
US6887258B2 (en) * 2002-06-26 2005-05-03 Advanced Cardiovascular Systems, Inc. Embolic filtering devices for bifurcated vessels
US7115134B2 (en) * 2002-07-22 2006-10-03 Chambers Technology, Llc. Catheter with flexible tip and shape retention
US7303575B2 (en) 2002-08-01 2007-12-04 Lumen Biomedical, Inc. Embolism protection devices
US8114114B2 (en) * 2002-08-27 2012-02-14 Emboline, Inc. Embolic protection device
US7174636B2 (en) 2002-09-04 2007-02-13 Scimed Life Systems, Inc. Method of making an embolic filter
US20060015136A1 (en) * 2002-09-19 2006-01-19 Memory Metal Holland Bv Vascular filter with improved strength and flexibility
US7313445B2 (en) 2002-09-26 2007-12-25 Medtronic, Inc. Medical lead with flexible distal guidewire extension
US7493154B2 (en) 2002-10-23 2009-02-17 Medtronic, Inc. Methods and apparatus for locating body vessels and occlusions in body vessels
US7323001B2 (en) * 2003-01-30 2008-01-29 Ev3 Inc. Embolic filters with controlled pore size
WO2004071343A2 (en) 2003-02-11 2004-08-26 Cook, Inc. Removable vena cava filter
US7740644B2 (en) 2003-02-24 2010-06-22 Boston Scientific Scimed, Inc. Embolic protection filtering device that can be adapted to be advanced over a guidewire
US20060041188A1 (en) 2003-03-25 2006-02-23 Dirusso Carlo A Flexible endoscope
WO2004087018A2 (en) 2003-03-28 2004-10-14 Ev3 Inc. Double ended intravascular medical device
US7597704B2 (en) 2003-04-28 2009-10-06 Atritech, Inc. Left atrial appendage occlusion device with active expansion
US6969396B2 (en) 2003-05-07 2005-11-29 Scimed Life Systems, Inc. Filter membrane with increased surface area
JP2006526464A (en) 2003-06-05 2006-11-24 フローメディカ,インコーポレイテッド System and method for performing bilateral intervention or diagnosis in a branched body lumen
US7537600B2 (en) 2003-06-12 2009-05-26 Boston Scientific Scimed, Inc. Valved embolic protection filter
US7722634B2 (en) 2003-07-03 2010-05-25 Regents Of The University Of Minnesota Medical device and method of intravenous filtration
US7879062B2 (en) 2003-07-22 2011-02-01 Lumen Biomedical, Inc. Fiber based embolism protection device
US7371248B2 (en) * 2003-10-14 2008-05-13 Medtronic Vascular, Inc. Steerable distal protection guidewire and methods of use
US8048103B2 (en) * 2003-11-06 2011-11-01 Boston Scientific Scimed, Inc. Flattened tip filter wire design
US7998104B2 (en) 2003-11-21 2011-08-16 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
US7651514B2 (en) 2003-12-11 2010-01-26 Boston Scientific Scimed, Inc. Nose rider improvement for filter exchange and methods of use
US20050137696A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Apparatus and methods for protecting against embolization during endovascular heart valve replacement
JP2005185386A (en) 2003-12-25 2005-07-14 Asahi Intecc Co Ltd Medical guide wire
US7976562B2 (en) 2004-01-22 2011-07-12 Rex Medical, L.P. Method of removing a vein filter
US7637903B2 (en) 2004-02-09 2009-12-29 Cryocor, Inc. Catheter articulation segment with alternating cuts
US7988705B2 (en) 2004-03-06 2011-08-02 Lumen Biomedical, Inc. Steerable device having a corewire within a tube and combination with a functional medical component
US8092483B2 (en) 2004-03-06 2012-01-10 Medtronic, Inc. Steerable device having a corewire within a tube and combination with a functional medical component
JP3626488B1 (en) 2004-03-15 2005-03-09 朝日インテック株式会社 Medical guidewire
US7559925B2 (en) * 2006-09-15 2009-07-14 Acclarent Inc. Methods and devices for facilitating visualization in a surgical environment
US8409237B2 (en) 2004-05-27 2013-04-02 Medtronic, Inc. Emboli filter export system
US7544202B2 (en) 2004-06-25 2009-06-09 Angiodynamics, Inc. Retrievable blood clot filter
WO2006055052A2 (en) 2004-07-19 2006-05-26 Michael Gertner Methods and devices for chronic embolic protection
US20080154153A1 (en) 2004-08-25 2008-06-26 Heuser Richard R Multiple-wire systems and methods for ablation of occlusions within blood vessels
WO2006026371A1 (en) 2004-08-27 2006-03-09 Cook Incorporated Placement of multiple intraluminal medical devices within a body vessel
US20060047301A1 (en) 2004-09-02 2006-03-02 Ogle Matthew F Emboli removal system with oxygenated flow
US7621904B2 (en) 2004-10-21 2009-11-24 Boston Scientific Scimed, Inc. Catheter with a pre-shaped distal tip
US20080086110A1 (en) 2004-11-19 2008-04-10 Galdonik Jason A Extendable Device On An Aspiration Catheter
US9510930B2 (en) 2008-10-22 2016-12-06 Contego Medical, Llc Angioplasty device with embolic filter
US9545300B2 (en) 2004-12-22 2017-01-17 W. L. Gore & Associates, Inc. Filament-wound implantable devices
US20060161241A1 (en) * 2005-01-14 2006-07-20 Denise Barbut Methods and devices for treating aortic atheroma
GB0501346D0 (en) * 2005-01-21 2005-03-02 Oxford Instr Molecular Biotool Method of carrying out dynamic nuclear polarization
US20060259066A1 (en) 2005-04-28 2006-11-16 Euteneuer Charles L Bifurcated artery filter system
US20080172066A9 (en) 2005-07-29 2008-07-17 Galdonik Jason A Embolectomy procedures with a device comprising a polymer and devices with polymer matrices and supports
US8021351B2 (en) 2005-08-18 2011-09-20 Medtronic Vascular, Inc. Tracking aspiration catheter
US8632562B2 (en) 2005-10-03 2014-01-21 Cook Medical Technologies Llc Embolic protection device
US7736346B2 (en) 2005-10-18 2010-06-15 Biocardia, Inc. Bio-interventional therapeutic treatments for cardiovascular diseases
DE102005059670A1 (en) * 2005-12-12 2007-06-14 Phenox Gmbh Device for removing thrombi from blood vessels
US7374567B2 (en) 2006-01-25 2008-05-20 Heuser Richard R Catheter system for connecting adjacent blood vessels
US20070208302A1 (en) 2006-01-26 2007-09-06 Webster Mark W Deflection control catheters, support catheters and methods of use
EP3075332B1 (en) 2006-02-13 2018-05-16 RetroVascular, inc. Recanalizing occluded vessels using controlled antegrade and retrograde tracking
US20070225750A1 (en) * 2006-03-10 2007-09-27 Brooke Ren Embolic protection systems
US8092470B2 (en) 2006-06-08 2012-01-10 Olympus Medical Systems Corp. Calculus crushing apparatus and medical procedure using endoscope
US20080234722A1 (en) * 2006-06-14 2008-09-25 Possis Medical, Inc. Inferior vena cava filter on guidewire
WO2008005898A2 (en) * 2006-06-30 2008-01-10 Ev3 Endovascular, Inc. Medical devices with amorphous metals and methods therefor
US20100179647A1 (en) * 2006-09-11 2010-07-15 Carpenter Judith T Methods of reducing embolism to cerebral circulation as a consequence of an index cardiac procedure
US9339367B2 (en) * 2006-09-11 2016-05-17 Edwards Lifesciences Ag Embolic deflection device
US9480548B2 (en) * 2006-09-11 2016-11-01 Edwards Lifesciences Ag Embolic protection device and method of use
US20100179584A1 (en) * 2006-09-11 2010-07-15 Carpenter Judith T Methods of diverting embolic debris away from the cerebral circulation
US20100179583A1 (en) * 2006-09-11 2010-07-15 Carpenter Judith T Methods of deploying and retrieving an embolic diversion device
US8460335B2 (en) 2006-09-11 2013-06-11 Embrella Cardiovascular, Inc. Method of deflecting emboli from the cerebral circulation
US20100324589A1 (en) 2006-09-11 2010-12-23 Carpenter Judith T Embolic deflection device
WO2008066881A1 (en) 2006-11-29 2008-06-05 Amir Belson Embolic protection device
US20080147013A1 (en) * 2006-12-18 2008-06-19 Breton Thomas G Catheter shape-retaining cover
US8333783B2 (en) 2007-02-16 2012-12-18 Reverse Medical Corporation Occlusion device and method of use
JP2010521264A (en) * 2007-03-20 2010-06-24 マンヴァシス Device and method for stent delivery and embolism prevention
US7717624B2 (en) * 2007-04-17 2010-05-18 Medeikon Corporation Connectors for multi fiber optical probes
JP5362708B2 (en) 2007-05-31 2013-12-11 ボストン サイエンティフィック リミテッド Flexible endoscope
US8157760B2 (en) 2007-07-18 2012-04-17 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US8062328B2 (en) * 2007-09-07 2011-11-22 Merit Medical Systems, Inc. Percutaneous permanent retrievable vascular filter
EP2219556B1 (en) * 2007-11-15 2015-07-08 Gore Enterprise Holdings, Inc. Hybrid intraluminal device
CA2713341C (en) * 2008-02-05 2016-09-27 Cvdevices, Llc Steering engagement catheter devices, systems, and methods
US8858609B2 (en) * 2008-02-07 2014-10-14 Intuitive Surgical Operations, Inc. Stent delivery under direct visualization
EP2273947B1 (en) * 2008-04-03 2018-05-16 Cook Medical Technologies LLC Self cleaning devices and systems
WO2009137712A1 (en) 2008-05-07 2009-11-12 Guided Delivery Systems Inc. Deflectable guide
US9061119B2 (en) * 2008-05-09 2015-06-23 Edwards Lifesciences Corporation Low profile delivery system for transcatheter heart valve
US9101735B2 (en) * 2008-07-07 2015-08-11 Intuitive Surgical Operations, Inc. Catheter control systems
US8070694B2 (en) 2008-07-14 2011-12-06 Medtronic Vascular, Inc. Fiber based medical devices and aspiration catheters
US8574245B2 (en) 2008-08-13 2013-11-05 Silk Road Medical, Inc. Suture delivery device
EP2385856B1 (en) 2009-01-09 2019-06-05 Embrella Cardiovascular, Inc. Embolic deflection device
US9326843B2 (en) 2009-01-16 2016-05-03 Claret Medical, Inc. Intravascular blood filters and methods of use
US9636205B2 (en) 2009-01-16 2017-05-02 Claret Medical, Inc. Intravascular blood filters and methods of use
US8372108B2 (en) 2009-01-16 2013-02-12 Claret Medical, Inc. Intravascular blood filter
US20170202657A1 (en) 2009-01-16 2017-07-20 Claret Medical, Inc. Intravascular blood filters and methods of use
WO2010088520A2 (en) 2009-01-29 2010-08-05 Claret Medical, Inc. Illuminated intravascular blood filter
US20100228280A1 (en) 2009-03-09 2010-09-09 Adam Groothuis Methods and devices for treatment of lumenal systems
US8974489B2 (en) 2009-07-27 2015-03-10 Claret Medical, Inc. Dual endovascular filter and methods of use
US20120046739A1 (en) 2010-04-14 2012-02-23 Randolf Von Oepen Method of delivering a medical device across a plurality of valves
US20120203265A1 (en) 2010-10-14 2012-08-09 Heuser Richard R Embolism protection device
US20120095500A1 (en) 2010-10-14 2012-04-19 Heuser Richard R Concentric wire embolism protection device
US9492264B2 (en) 2010-12-30 2016-11-15 Claret Medical, Inc. Embolic protection device for protecting the cerebral vasculature
EP2658476B1 (en) 2010-12-30 2022-04-06 Boston Scientific Scimed, Inc. Intravascular blood filter
EP2530583B1 (en) 2011-05-31 2019-11-27 Accenture Global Services Limited Computer-implemented method, system and computer program product for displaying a user interface component
US20130123835A1 (en) 2011-11-14 2013-05-16 Boston Scientific Scimed, Inc. Embolic protection device and method
US20130131714A1 (en) 2011-11-14 2013-05-23 Boston Scientific Scimed, Inc. Embolic protection device and methods of making the same
US20150039016A1 (en) 2012-03-09 2015-02-05 Keystone Heart Ltd. Device and method for deflecting emboli in an aorta
US20140052170A1 (en) 2012-08-17 2014-02-20 Richard R. Heuser Embolism protection device
WO2014059005A1 (en) 2012-10-09 2014-04-17 Boston Scientific Scimed, Inc. Special opening aortic embolic protection device for structural heart procedures
US9211179B2 (en) 2013-02-26 2015-12-15 Medtronic, Inc. Embolic protection device
EP2859864A1 (en) 2013-10-14 2015-04-15 Protembis GmbH Medical device for embolic protection
US9566144B2 (en) 2015-04-22 2017-02-14 Claret Medical, Inc. Vascular filters, deflectors, and methods

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375628B1 (en) * 1997-03-06 2002-04-23 Medtronic Percusurge, Inc. Hollow medical wires and methods of constructing same
US20070043259A1 (en) * 2000-04-03 2007-02-22 Ross Jaffe Endoscope Having a Guide Tube
US20020072764A1 (en) * 2000-06-29 2002-06-13 Concentric Medical, Inc. Systems, method and devices for removing obstructions from a blood vessel
US20060100658A1 (en) * 2004-11-09 2006-05-11 Hiroyuki Obana Interventional guiding sheath system and method of use
US20060135961A1 (en) * 2004-12-17 2006-06-22 Biocardia, Inc. Steerable guide catheters and methods for their use
US20070005131A1 (en) * 2005-06-13 2007-01-04 Taylor David M Heart valve delivery system
US20080275485A1 (en) * 2006-04-03 2008-11-06 Possis Medical, Inc. Guidewire with collapsible filter system and method of use
US20090326575A1 (en) * 2008-06-23 2009-12-31 Galdonik Jason A Embolic protection during percutaneous heart valve replacement and similar procedures

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12048618B2 (en) 2009-01-16 2024-07-30 Boston Scientific Scimed, Inc. Intravascular blood filter
US11607301B2 (en) 2009-01-16 2023-03-21 Boston Scientific Scimed, Inc. Intravascular blood filters and methods of use
US11364106B2 (en) 2009-01-16 2022-06-21 Boston Scientific Scimed, Inc. Intravascular blood filter
US11284986B2 (en) 2009-01-16 2022-03-29 Claret Medical, Inc. Intravascular blood filters and methods of use
US9326843B2 (en) 2009-01-16 2016-05-03 Claret Medical, Inc. Intravascular blood filters and methods of use
US10743977B2 (en) 2009-01-16 2020-08-18 Boston Scientific Scimed, Inc. Intravascular blood filter
US9636205B2 (en) 2009-01-16 2017-05-02 Claret Medical, Inc. Intravascular blood filters and methods of use
US10130458B2 (en) 2009-07-27 2018-11-20 Claret Medical, Inc. Dual endovascular filter and methods of use
US8974489B2 (en) 2009-07-27 2015-03-10 Claret Medical, Inc. Dual endovascular filter and methods of use
US8753370B2 (en) 2009-07-27 2014-06-17 Claret Medical, Inc. Dual endovascular filter and methods of use
US11191631B2 (en) 2009-07-27 2021-12-07 Boston Scientific Scimed, Inc. Dual endovascular filter and methods of use
US9345565B2 (en) 2010-12-30 2016-05-24 Claret Medical, Inc. Steerable dual filter cerebral protection system
US9259306B2 (en) 2010-12-30 2016-02-16 Claret Medical, Inc. Aortic embolic protection device
US10058411B2 (en) 2010-12-30 2018-08-28 Claret Madical, Inc. Method of isolating the cerebral circulation during a cardiac procedure
US9943395B2 (en) 2010-12-30 2018-04-17 Claret Medical, Inc. Deflectable intravascular filter
US9980805B2 (en) 2010-12-30 2018-05-29 Claret Medical, Inc. Aortic embolic protection device
US8876796B2 (en) 2010-12-30 2014-11-04 Claret Medical, Inc. Method of accessing the left common carotid artery
US11141258B2 (en) 2010-12-30 2021-10-12 Claret Medical, Inc. Method of isolating the cerebral circulation during a cardiac procedure
US9017364B2 (en) 2010-12-30 2015-04-28 Claret Medical, Inc. Deflectable intravascular filter
US9492264B2 (en) 2010-12-30 2016-11-15 Claret Medical, Inc. Embolic protection device for protecting the cerebral vasculature
US9055997B2 (en) 2010-12-30 2015-06-16 Claret Medical, Inc. Method of isolating the cerebral circulation during a cardiac procedure
US10314600B2 (en) 2012-05-21 2019-06-11 Noha, Llc Clot removal device and method of using same
US10449028B2 (en) 2015-04-22 2019-10-22 Claret Medical, Inc. Vascular filters, deflectors, and methods
US9566144B2 (en) 2015-04-22 2017-02-14 Claret Medical, Inc. Vascular filters, deflectors, and methods
US11337790B2 (en) 2017-02-22 2022-05-24 Boston Scientific Scimed, Inc. Systems and methods for protecting the cerebral vasculature
US11191630B2 (en) 2017-10-27 2021-12-07 Claret Medical, Inc. Systems and methods for protecting the cerebral vasculature
US12097108B2 (en) 2017-10-27 2024-09-24 Claret Medical, Inc. Systems and methods for protecting the cerebral vasculature
US11154390B2 (en) 2017-12-19 2021-10-26 Claret Medical, Inc. Systems for protection of the cerebral vasculature during a cardiac procedure
US12064332B2 (en) 2017-12-19 2024-08-20 Claret Medical, Inc. Systems and methods for protecting the cerebral vasculature
US11439491B2 (en) 2018-04-26 2022-09-13 Claret Medical, Inc. Systems and methods for protecting the cerebral vasculature
US11351023B2 (en) 2018-08-21 2022-06-07 Claret Medical, Inc. Systems and methods for protecting the cerebral vasculature

Also Published As

Publication number Publication date
US8372108B2 (en) 2013-02-12
EP2387427A2 (en) 2011-11-23
ES2516066T3 (en) 2014-10-30
US20220280274A1 (en) 2022-09-08
WO2010083527A3 (en) 2010-10-21
EP2387427B1 (en) 2014-08-27
US20200345473A1 (en) 2020-11-05
US10743977B2 (en) 2020-08-18
US20100185231A1 (en) 2010-07-22
WO2010083527A2 (en) 2010-07-22
EP2387427A4 (en) 2013-01-02
US11364106B2 (en) 2022-06-21
US12048618B2 (en) 2024-07-30
US20180177582A1 (en) 2018-06-28

Similar Documents

Publication Publication Date Title
US12048618B2 (en) Intravascular blood filter
US8518073B2 (en) Illuminated intravascular blood filter
US20240285388A1 (en) Method of isolating the cerebral circulation during a cardiac procedure
US20220192812A1 (en) Intravascular blood filters and methods of use
US11607301B2 (en) Intravascular blood filters and methods of use
US9636205B2 (en) Intravascular blood filters and methods of use
EP2658476A1 (en) Intravascular blood filters and methods of use
US12133657B2 (en) Clot retrieval device for removing occlusive clot from a blood vessel
US20220023025A1 (en) Method of isolating the cerebral circulation during a cardiac procedure

Legal Events

Date Code Title Description
AS Assignment

Owner name: CLARET MEDICAL, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LASHINSKI, RANDALL T.;REEL/FRAME:041753/0751

Effective date: 20100205

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION